Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-15-002731
Filing Date
2015-08-14
Accepted
2015-08-14 16:06:22
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cocp10q_june302015.htm 10-Q 640133
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER (302) ex31-1.htm EX-31.1 11254
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER (302) ex31-2.htm EX-31.2 11917
4 CERTIFICATION OF PRINCIPAL EXECUTIVE AND PRINCIPAL FINANCIAL OFFICER (906) ex32-1.htm EX-32.1 8542
  Complete submission text file 0001415889-15-002731.txt   2648860

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cocp-20150630.xml EX-101.INS 331746
6 XBRL TAXONOMY EXTENSION SCHEMA cocp-20150630.xsd EX-101.SCH 33993
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cocp-20150630_cal.xml EX-101.CAL 41480
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cocp-20150630_def.xml EX-101.DEF 105790
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cocp-20150630_lab.xml EX-101.LAB 216122
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cocp-20150630_pre.xml EX-101.PRE 187208
Mailing Address 19805 NORTH CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 NORTH CREEK PARKWAY BOTHELL WA 98011 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55158 | Film No.: 151055714
SIC: 2834 Pharmaceutical Preparations